Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ingevity (NGVT) Operating Expenses (2016 - 2025)

Ingevity (NGVT) has disclosed Operating Expenses for 11 consecutive years, with $60.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 63.86% to $60.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $212.4 million, a 14.56% increase, with the full-year FY2025 number at $212.4 million, up 16.32% from a year prior.
  • Operating Expenses was $60.3 million for Q4 2025 at Ingevity, up from $49.3 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $68.7 million in Q3 2022 to a low of $36.8 million in Q4 2024.
  • A 5-year average of $54.4 million and a median of $52.4 million in 2021 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: plummeted 46.04% in 2024, then skyrocketed 63.86% in 2025.
  • Ingevity's Operating Expenses stood at $55.0 million in 2021, then rose by 20.55% to $66.3 million in 2022, then grew by 2.87% to $68.2 million in 2023, then crashed by 46.04% to $36.8 million in 2024, then soared by 63.86% to $60.3 million in 2025.
  • Per Business Quant, the three most recent readings for NGVT's Operating Expenses are $60.3 million (Q4 2025), $49.3 million (Q3 2025), and $39.7 million (Q2 2025).